This is a Phase 2 Study is to determine the efficacy and safety rate of B-Cell Acute Lymphoblastic Leukemia (B-ALL) participants in remission with minimal resi…

B-Cell Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia

~Estimated

~$10 – $6,250

H. Lee Moffitt Cancer Center and Research InstituteNCT06144606

Blinatumomab's Outcome On Serologic Titers and Efficacy of Revaccination

The goal of this observational study is to establish a clear vaccination protocol for pediatric patients (less than 21 years old) who have received treatment f…

B-Cell ALLB-Cell Acute Lymphoblastic LeukaemiaB-Cell Lymphoblastic Leukemia+5 more

~Estimated

~$10 – $750

Arkansas Children's Hospital Research InstituteNCT07422337